244 related articles for article (PubMed ID: 30209801)
1. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology.
Góralska M; Bednarczuk T; Rosłon M; Libura M; Szalecki M; Hilczer M; Stawerska R; Smyczyńska J; Karbownik-Lewińska M; Walczak M; Lewiński A
Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209801
[TBL] [Abstract][Full Text] [Related]
2. Growth Hormone Treatment for Prader-Willi Syndrome.
Tauber M; Diene G; Molinas C
Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
[TBL] [Abstract][Full Text] [Related]
3. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
4. The use of medical care and the prevalence of serious illness in an adult Prader-Willi syndrome cohort.
Sinnema M; Maaskant MA; van Schrojenstein Lantman-de Valk HM; Boer H; Curfs LM; Schrander-Stumpel CT
Eur J Med Genet; 2013 Aug; 56(8):397-403. PubMed ID: 23792791
[TBL] [Abstract][Full Text] [Related]
5. Management of Prader-Labhart-Willi syndrome in children and in adults, with particular emphasis on the treatment with recombinant human growth hormone.
Drabik M; Lewiński A; Stawerska R
Pediatr Endocrinol Diabetes Metab; 2022; 28(1):64-74. PubMed ID: 35307998
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
Grugni G; Marzullo P
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
[TBL] [Abstract][Full Text] [Related]
7. Disease management of Prader-Willi syndrome.
Lee PD
Expert Opin Pharmacother; 2002 Oct; 3(10):1451-9. PubMed ID: 12387691
[TBL] [Abstract][Full Text] [Related]
8. Benefits of multidisciplinary care in Prader-Willi syndrome.
Salvatoni A; Nosetti L; Salvatore S; Agosti M
Expert Rev Endocrinol Metab; 2021 Mar; 16(2):63-71. PubMed ID: 33724138
[No Abstract] [Full Text] [Related]
9. EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME - OUR FIRST EXPERIENCES.
Stipančić G; Požgaj Šepec M; La Grasta Sabolić L
Acta Clin Croat; 2018 Dec; 57(4):744-755. PubMed ID: 31168212
[TBL] [Abstract][Full Text] [Related]
10. [Clinical aspects and genetics of Prader-Willi syndrome].
Rittinger O
Klin Padiatr; 2001; 213(3):91-8. PubMed ID: 11417368
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone treatment in a girl with Prader Willi syndrome.
Pandey SN; Vaidya RA; Irani A
Indian J Pediatr; 2003 Apr; 70(4):351-3. PubMed ID: 12793314
[TBL] [Abstract][Full Text] [Related]
12. Associations between cognitive performance and the rehabilitation, medical care and social support provided to French children with Prader-Willi syndrome.
Roux-Levy PH; Bournez M; Masurel A; Jean N; Chancenotte S; Bordes M; Debomy F; Minot D; Schmitt E; Vinault S; Gautier E; Lacombe D; Odent S; Mikaty M; Manouvrier S; Ghoumid J; Geneviève D; Lehman N; Philip N; Edery P; Cornaton J; Gallard J; Héron D; Rastel C; Huet F; Thauvin-Robinet C; Verloes A; Binquet C; Tauber M; Lejeune C; Faivre L
Eur J Med Genet; 2020 Dec; 63(12):104064. PubMed ID: 32998064
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China.
Yang-Li D; Fei-Hong L; Hui-Wen Z; Ming-Sheng M; Xiao-Ping L; Li L; Yi W; Qing Z; Yong-Hui J; Chao-Chun Z; ;
Orphanet J Rare Dis; 2022 Jun; 17(1):221. PubMed ID: 35698200
[TBL] [Abstract][Full Text] [Related]
14. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone prescribing patterns in the UK, 2013-2016.
Shepherd S; Saraff V; Shaw N; Banerjee I; Patel L
Arch Dis Child; 2019 Jun; 104(6):583-587. PubMed ID: 30567827
[TBL] [Abstract][Full Text] [Related]
16. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
Deal CL; Tony M; Höybye C; Allen DB; Tauber M; Christiansen JS;
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1072-87. PubMed ID: 23543664
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
18. Treatment with growth hormone in the prader-willi syndrome.
Moix Gil E; Giménez-Palop O; Caixàs A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Apr; 65(4):229-236. PubMed ID: 29510967
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis.
Sanchez-Ortiga R; Klibanski A; Tritos NA
Clin Endocrinol (Oxf); 2012 Jul; 77(1):86-93. PubMed ID: 22117629
[TBL] [Abstract][Full Text] [Related]
20. A questionnaire-based survey of medical conditions in adults with Prader-Willi syndrome in Japan: implications for transitional care.
Kawai M; Muroya K; Murakami N; Ihara H; Takahashi Y; Horikawa R; Ogata T
Endocr J; 2023 May; 70(5):519-528. PubMed ID: 36792176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
